Chemcon Special. (CHEMCON)

Cyclical

FairStock Score: 22/100 — RISKY

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹191.14
Market Cap₹700.16 Cr
P/E Ratio24.89
ROCE7.01%
ROE4.34%
Dividend Yield6.8%
Profit Growth71.6%
Debt/Equity0.11
Sales Growth16.17%
Promoter Holding74.47%
52-Week Range₹125 — ₹257.4
SectorChemicals & Petrochemicals
Book Value₹131.95

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

Let me start with the obvious: a 42% drop in profit while sales rise 5% tells me this is not a business with pricing power. In my world, you want a company that earns high returns on capital. Chemcon's ROE is 4.34% and ROCE is 7.01% – I could get that in a fixed deposit without worrying about quarterly slides. The balance sheet is clean, with zero debt, and promoters own 74.47%, so skin in the game is not the issue. But a clean balance sheet only helps if management can deploy capital profitably. At ₹162.75, the market caps the company at ₹603 Cr, which is 28.45 times trailing earnings. That is not cheap when earnings are falling by 42%. The book value is ₹134.60, so the P/B of 1.21 offers some asset support, yet the return on that book is poor. The Piotroski score of 4 out of 9 and the FairStock score of 9/100 both warn me to be cautious. There is no dividend, so my return depends entirely on future business improvement. This smells like a cyclical downturn or a company in need of a genuine turnaround. I don't buy stories; I need evidence of margin recovery and higher cash flows. The latest quarter's ₹5 Cr profit at least shows it is still profitable, but I need to see that trend sustained. Until then, this goes on my watchlist, not my wallet.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer